[S-22] Symposium 22
Latest Advances in the Treatment of Ischemic Stroke

[S-22-3] Muse Cell Therapy for Cerebral Ischemia

^○Kuniyasu Niizuma^1,2,3, Teiji Tominaga³ (1.Department of Neurosurgical Engineering and Translational Neuroscience, Graduate School of Biomedical Engineering, Tohoku University, Japan, 2.Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Medicine, Japan, 3.Department of Neurosurgery, Tohoku University Graduate School of Medicine, Japan)

Advances in endovascular treatment, there is a number of topics including prevention of ischemia reperfusion injury, neuroprotection therapy, cell transplantation therapy, in the field of cerebral ischemic pathological mechanism. In this symposium, we focus on modulation of post-stroke inflammation, promoting collateral circulation and cell replacement therapies, discussing the future applications of in post-stroke patients.

Education
1997-2003 M.D., Tohoku University School of Medicine
2005-2009 Ph.D., Tohoku University Graduate School of Medicine

Postgraduate Training and Fellowship Appointments
2003-2010 Resident in Neurosurgery, Tohoku University (Japan)
2006-2009 Postdoctoral Fellow, Department of Neurosurgery, Stanford University School of Medicine (Stanford, USA)

Faculty Appointments
2010 Assistant Professor, Department of Neurosurgery, Tohoku University Graduate School of Medicine
2012 Clinical Associate Professor, Department of Neurosurgery, Tohoku University Graduate School of Medicine
2014 Assistant Professor, Department of Neurosurgery, Tohoku University Graduate School of Medicine
2017 Lecturer, Department of Neurosurgery, Tohoku University Graduate School of Medicine
2018-Present Professor, Department of Neurosurgical Engineering and Translational Neuroscience, Graduate School of Biomedical Engineering, Tohoku University